A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Safety And Efficacy Of PPM-204 In Subjects With Type 2 Diabetes
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Safety And Efficacy Of PPM-204 In Subjects With Type 2 Diabetes
The purpose of this study is to learn whether PPM-204 has an effect on lowering blood glucose (blood sugar) levels and is safe in treating people with type 2 diabetes.
The objectives of the study are to identify doses of PPM-204 that are therapeutically effective and well tolerated in improving glycemic control over 24 weeks of treatment in subjects with type 2 diabetes mellitus (T2DM).
Inclusion Criteria:
Exclusion Criteria:
Mar Del Plata Pcia de Bs. As, 7600, Argentina
Daws Park, South Australia 5041, Australia
Vila Clementino - Sao Paulo, 04020-060, Brazil
Monterrey N.L, 64410, Mexico
Tlapan, 14080, Mexico
Belgrade, 11000, Serbia and Montenegro
Temba, North West 400, South Africa